Second interim analysis of a phase 3 study evaluating idelalisib and rituximab for relapsed chronic lymphocytic leukemia by Ghia, P, Coutre, S.E, Furman, R.R, Sharman, J.P, Cheson, B.D, Pagel, J.M, Hillmen, P, Barrientos, J.C, Zelenetz, A.D, Kipps, T.J, Flinn, I.W, Eradat, H.A, Lamanna, N, Coiffier, B, Pettitt, A, Li, X, Jahn, T.M, O'Brien, S.M, Hallek, M.J

Get full text

253P Digital decision support for structural improvement of lung cancer tumor boards: Using standard cases to optimize workflow by Gross-Ophoff-Mueller, C., Hoier, D., Oden, A., Hallek, M.J., Greeske, A., Heidelbach, J., Elter, T.

Get full text

4.25 Update on the International Standardized Approach for Flow Cytometric Residual Disease Monitoring in CLL by Rawstron, A.C, Böttcher, S, Letestu, R, Villamor, N, Fazi, C, Kartsios, H, de Tute, R, Shingles, J, Ritgen, M, Moreno, C, Kneba, M, Montserrat, E, Cymbalista, F, Hallek, M.J, Hillmen, P, Ghia, P

Get full text

International Standardized Approach to Molecular and Flow Cytometric Residual Disease Monitoring in CLL by Rawstron, A.C., Villamor, N., Zehnder, J.L., Ghia, P., Ritgen, M., Bottcher, S., Lozanski, G., Mone, A.P., Colomer, D., Moreno, C., Geuna, M., Evans, P.A., Kneba, M., Natkunam, Y., Coutre, S.E., Caligaris-Cappio, F., Hallek, M.J., Byrd, J.C., Montserrat, E., Hillmen, P.

Get full text

Transplantation hämatopoetischer Stammzellen: Knochenmark und Blutstammzellen by von Bergwelt-Baildon, M., Holtick, U., Hallek, M.J., Scheid, C.

Get full text